Extend Biosciences’ Founder Laura Hales Speaks on a Panel on Women in STEM at a Regional SBIR Conference

Laura Hales, Cofounder of Extend Biosciences, spoke about her journey in biotech and entrepreneurship and path to successfully obtaining SBIR funding on a panel on October 5. The panel was moderated by Esther Morales, Executive Director of the National Women’s Business Council, and included Barbara Fox, PhD, Marian Nakada, PhD, and Joanne Kamens, PhD. The title of the panel was “It’s All of Our Business: Succeeding as a Woman in STEM” and was part of the preconference to the 2016 SBIR New England Regional Summit at MIT.

Extend Biosciences Featured in the NSF Innovation Zone at BIO2016

Extend Biosciences was featured in the NSF Innovation Zone at the BIO International Convention 2016 in San Francisco, CA.  The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.

Read the press release here->

Extend Biosciences has been Awarded a Second Patent with Broad Claims

Extend Biosciences’ second patent has been awarded by the USPTO. The patent, titled “Carriers for Improved Drug Delivery” issued March 22, 2016 (US 9,289,507). The patent includes broad claims for the use of vitamin D to improve the pharmacokinetic properties of therapeutic entities.

CEO Tarik Soliman Speaks at the Peptide Showcase East Conference

Extend Biosciences’ CEO Tarik Soliman gave a talk at the Boulder Peptide Symposium’s Peptide Showcase East conference held at the Microsoft NERD Center in Cambridge, MA. The talk was titled “Harnessing the biology of Vitamin D to enable sustained delivery of peptides and proteins.”

Watch video here ->

Extend Biosciences’ First Patent has been Awarded by the USPTO

Extend Biosciences’ first patent has been awarded. The patent, titled “Vitamin D-ghrelin Conjugates” issued Nov. 3, 2015 (US 9,173,940).

Extend Biosciences Featured in the Innovation Zone at the BIO2015 International Convention

Extend Biosciences was one of 12 NSF awardee companies with treatment-related technologies that was featured in the Innovation Zone at the BIO International Convention 2015 in Philadelphia, PA.  The company received complimentary passes to the Convention, and the technology was showcased at the company’s kiosk in the Innovation Zone with a poster and a pitch presentation by CEO Tarik Soliman.

See the press release here ->

Extend Biosciences and LabCentral Resident Companies Featured in Science Magazine Article

Extend Biosciences and LabCentral companies Vaxess, Ymir Genomics, Advirna and others are featured in an article in Science magazine as part of a special issue on entrepreneurship. The article is titled, “Got a Startup? Rent a Bench”.

Read the article here ->

Extend Biosciences Selected to Receive MLSC MAP Grant

Extend Biosciences has been awarded a Milestone Achievement Program (MAP) grant of $200,000 from the Massachusetts Life Sciences Center. The company was one of twelve early-stage life sciences companies that was selected for an award in this new program.

See press release here ->

Extend Biosciences’ Founder Laura M. Hales, Ph.D. Selected to Speak on a Biotech Entrepreneur Panel

Founder Laura M. Hales, Ph.D. spoke on a panel of women entrepreneurs at the “From Bench to Bedside: An Evening With Biotech Entrepreneurs” event sponsored by Tufts Biomedical Business Club and the Boston Entrepreneurs and Advanced Degrees Meetup Group (B.E.A.D.). The panel also featured Dr. Bonnie Fendrock (Cofounder and CEO of Cyta Therapeutics), Dr. Kathryn Kosuda (Cofounder and VP of Research and Development of Vaxess Technologies), and Cinzia Metallo (Founder and Managing Director at Biomille Technologies). The lively and interactive panel was moderated by Dr. Paulina Hill of Polaris Ventures.

See Ania Wronski’s Storify on the event ->

Extend Biosciences is Awarded a Phase II grant from the National Science Foundation

The NSF awarded a Phase II grant to Extend Biosciences’ PI Tarik M. Soliman, Ph.D. for a project titled “A platform technology that significantly improves drug delivery”.

View NSF’s website here ->